| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Wound Healing Research Unit, Department of Pathology, Institute of Ophthalmology, London, United Kingdom; and Moorfields Eye Hospital, London, United Kingdom.
PURPOSE. To determine whether postoperative application of a broad-spectrum matrix metalloproteinase (MMP) inhibitor, GM6001 (ilomastat), reduces scarring after glaucoma filtration surgery.
METHODS. In a randomized, prospective, masked-observer study, 40 New Zealand White rabbits underwent modified glaucoma filtration surgery. The animals were randomly allocated to receive postoperative subconjunctival injections of either phosphate-buffered saline (PBS) or 100 µM ilomastat for 10 days. The animals were killed on days 7, 14, 21, and 30. Clinical characteristics, which included bleb morphology and intraocular pressure, were recorded. Tissue sections were immunohistochemically stained for 
smooth muscle actin (SMA) and extracellular matrix components in the two groups.
RESULTS. Surgical outcome was significantly prolonged in the ilomastat-treated group compared with the vehicle-treated group (P < 0.001). At day 30, all the blebs had survived except two in the ilomastat-treated group, whereas no blebs survived to day 30 with vehicle treatment (n = 11). The intraocular pressure remained significantly lower throughout the course of the experiment in the ilomastat group compared with the vehicle group (P < 0.0017). Histologically, less scar tissue was observed at the sclerostomy site with inhibition of MMP, compared with vehicle treatment.
CONCLUSIONS. The data presented suggest that the healing response after surgery can be modulated by inhibiting the effects of MMPs. Inhibition of MMP significantly improved surgical outcome by reducing the amount of scar tissue produced. By targeting the actions of these proteolytic enzymes, a more controlled and physiological method of modulating scarring may be achieved.
This article has been cited by other articles:
|
|
 |
|
  Y. Liu, J.-A. Ko, R. Yanai, K. Kimura, T.-i. Chikama, T. Sagara, and T. Nishida Induction by Latanoprost of Collagen Gel Contraction Mediated by Human Tenon Fibroblasts: Role of Intracellular Signaling Molecules Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1429 - 1436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Honjo, H. Tanihara, T. Kameda, T. Kawaji, N. Yoshimura, and M. Araie Potential Role of Rho-Associated Protein Kinase Inhibitor Y-27632 in Glaucoma Filtration Surgery Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5549 - 5557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. T. L. Wong, A. L. Mead, and P. T. Khaw Prolonged Antiscarring Effects of Ilomastat and MMC after Experimental Glaucoma Filtration Surgery Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 2018 - 2022. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Grisanti, P. Szurman, M. Warga, R. Kaczmarek, F. Ziemssen, O. Tatar, and K. U. Bartz-Schmidt Decorin Modulates Wound Healing in Experimental Glaucoma Filtration Surgery: A Pilot Study Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 191 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Burton, R. L. Bailey, D. Jeffries, D. C. W. Mabey, and M. J. Holland Cytokine and Fibrogenic Gene Expression in the Conjunctivas of Subjects from a Gambian Community Where Trachoma Is Endemic Infect. Immun., December 1, 2004; 72(12): 7352 - 7356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Esson, M. P. Popp, L. Liu, G. S. Schultz, and M. B. Sherwood Microarray Analysis of the Failure of Filtering Blebs in a Rat Model of Glaucoma Filtering Surgery Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4450 - 4462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. H. Eibl, B. Banas, D. Kook, A. V. Ohlmann, S. Priglinger, A. Kampik, and U. C. Welge-Luessen Alkylphosphocholines: A New Therapeutic Option in Glaucoma Filtration Surgery Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2619 - 2624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T T L Wong, J T Daniels, J G Crowston, and P T Khaw MMP inhibition prevents human lens epithelial cell migration and contraction of the lens capsule Br. J. Ophthalmol., July 1, 2004; 88(7): 868 - 872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Csutak, D. M. Silver, J. Tozser, Z. Hassan, and A. Berta Urokinase-Type Plasminogen Activator to Prevent Haze after Photorefractive Keratectomy, and Pregnancy as a Risk Factor for Haze in Rabbits Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1329 - 1333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Daniels, G. S. Schultz, T. D. Blalock, Q. Garrett, G. R. Grotendorst, N. M. Dean, and P. T. Khaw Mediation of Transforming Growth Factor-{beta}1-Stimulated Matrix Contraction by Fibroblasts: A Role for Connective Tissue Growth Factor in Contractile Scarring Am. J. Pathol., November 1, 2003; 163(5): 2043 - 2052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Daniels, A. D. Cambrey, N. L. Occleston, Q. Garrett, R. W. Tarnuzzer, G. S. Schultz, and P. T. Khaw Matrix Metalloproteinase Inhibition Modulates Fibroblast-Mediated Matrix Contraction and Collagen Production In Vitro Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1104 - 1110. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
